CGEM analyst estimates
Cullinan Therapeutics (CGEM) analyst ratings, the average price target and its range, and every firm's latest call.
- 3 firms rate CGEM: 3 buy, 0 hold, 0 sell.
- The average price target is $34.33 from None analysts, from $27.00 to $41.00.
Updated 2026-11-10 04:45 UTC